Sélectionner une taille de conditionnement
A propos de cet article
usage
sufficient for 5 preparations
Quality Level
greener alternative product characteristics
Designing Safer Chemicals
Learn more about the Principles of Green Chemistry.
sustainability
Greener Alternative Product
technique(s)
DNA extraction: suitable
test parameters
sample volume: 2000 mL bacterial culture
greener alternative category
storage temp.
15-25°C
General description
An overnight recombinant E. coli culture is harvested by centrifugation and subjected to a modified alkaline-SDS lysis. The lysate is cleared by filtration followed by the addition of a binding solution optimized for endotoxin-free plasmid preparations. The plasmid DNA is then captured onto a silica membrane in the presence of high salts while endotoxins are prevented from adsorbing to the membrane. Contaminants are removed with three wash steps. Finally, the bound DNA is eluted in endotoxin-free water.
The DNA is ready for immediate use in applications such as restriction digest, cloning, sequencing, PCR, and transfection of endotoxin-sensitive cell lines.
Application
Features and Benefits
- Up to 15 mg with endotoxin levels of ≤ 0.1 EU/μg
- Only 90 minutes from pelleted cells to purified plasmid
- Vacuum format with no ethanol precipitation
- Can purify low-, medium-, and high-copy plasmid DNA
Other Notes
Legal Information
signalword
Danger
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 3 - Met. Corr. 1 - Resp. Sens. 1 - Skin Irrit. 2 - STOT RE 1 Inhalation - STOT SE 3
target_organs
Central nervous system, Lungs
Classe de stockage
3 - Flammable liquids
flash_point_f
77.0 °F - closed cup
flash_point_c
25 °C - closed cup
wgk
WGK 3
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Contenu apparenté
Outils pour la préparation des plasmides, la transcription in vitro, la purification de l'ARNm et la formulation des LNP dans le cadre du développement de vaccins et de thérapies à base d'ARNm.
Numéro d'article de commerce international
| Référence | GTIN |
|---|---|
| NA0800-1KT | 04061834119081 |



